Literature DB >> 29141071

Usefulness of Total 12-Lead QRS Voltage as a Clue to Diagnosis of Patients With Cardiac Sarcoidosis Severe Enough to Warrant Orthotopic Heart Transplant.

William C Roberts1,2,3, Tiffany M Becker1,2,3, Shelley A Hall1,2,3.   

Abstract

Importance: Severe heart failure caused by cardiac sarcoidosis is difficult to diagnosis without biopsy. Objective: To assess whether total electrocardiographic 12-lead QRS voltage may be a clue to diagnosis. Design, Setting, Participants: Case-series study with cases collected at Baylor University Medical Center at Dallas, Dallas, Texas, from January 13, 2005, to January 24, 2017. The clinical records of 16 patients with severe heart failure caused by cardiac sarcoidosis were studied. Examination of total 12-lead electrocardiographic QRS voltage (peak of the R wave to the nadir of either the Q or S wave, whichever was deeper) was performed prior to orthotopic heart transplant (OHT). Gross and microscopic pathologic specimens of the native hearts were studied. Main Outcomes and Measures: The primary outcome was to correlate the total 12-lead QRS voltage measurement with various morphologic features in the native diseased heart.
Results: The 16-patient study group consisted of 8 men and 8 women; 12 (75%) were white and 4 (25%) were black. At the time of OHT, patient age ranged from 50 to 67 years (mean, 57 years). Cardiac sarcoidosis was diagnosed by pre-OHT biopsy results in 2 (13%) patients and by examination of the native heart after OHT in 14 (87%) patients. Total nonpaced 12-lead QRS voltage mean was 117 mm (range, 52-155 mm) for 8 patients and total paced 12-lead QRS voltage was 90 mm (range, 67-161 mm) for 12 patients. These low mean values were similar to those of patients with carcinoid heart disease (mean [SD], 105 [40] mm), cardiac amyloidosis (104 [35] mm), and severe cardiac adiposity (120 [31] mm) studied at necropsy or after OHT. In contrast, mean (SD) values were 323 (109) mm in patients with massive cardiomegaly, 257 mm in patients with severe aortic stenosis, 272 (86) mm in patients with severe pure aortic regurgitation, 220 (67) mm in patients with severe pure mitral regurgitation, 197 (64) mm in patients with hypertrophic cardiomyopathy, and 153 (40) mm in patients with idiopathic dilated cardiomyopathy. Conclusions and Relevance: Most patients diagnosed with cardiac sarcoidosis causing severe heart failure and warranting OHT had low total 12-lead QRS voltage measurements despite having native hearts of increased weight. This finding may provide a clue to the diagnosis of this disease.

Entities:  

Mesh:

Year:  2018        PMID: 29141071      PMCID: PMC5833537          DOI: 10.1001/jamacardio.2017.4172

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  12 in total

1.  Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients.

Authors:  W C Roberts; B F Waller
Journal:  Am J Cardiol       Date:  1983-07       Impact factor: 2.778

2.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

Authors:  W C Roberts; R J Siegel; B M McManus
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

3.  Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation.

Authors:  J Shirani; B J Maron; R O Cannon; S Shahin; W C Roberts
Journal:  Am J Cardiol       Date:  1993-08-15       Impact factor: 2.778

4.  Electrocardiographic observations in clinically isolated, pure, chronic, severe aortic regurgitation: analysis of 30 necropsy patients aged 19 to 65 years.

Authors:  W C Roberts; P J Day
Journal:  Am J Cardiol       Date:  1985-02-01       Impact factor: 2.778

Review 5.  Comparison of total 12-lead QRS voltage in a variety of cardiac conditions and its usefulness in predicting increased cardiac mass.

Authors:  William C Roberts; Giovanni Filardo; Jong Mi Ko; Robert J Siegel; Allen L Dollar; Elizabeth M Ross; Jamshid Shirani
Journal:  Am J Cardiol       Date:  2013-06-14       Impact factor: 2.778

6.  Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy.

Authors:  R L Wilensky; P Yudelman; A I Cohen; R D Fletcher; J Atkinson; R Virmani; W C Roberts
Journal:  Am J Cardiol       Date:  1988-08-01       Impact factor: 2.778

7.  The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease.

Authors:  E M Ross; W C Roberts
Journal:  Am J Med       Date:  1985-09       Impact factor: 4.965

8.  Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy.

Authors:  A L Dollar; W C Roberts
Journal:  Am J Med       Date:  1989-10       Impact factor: 4.965

9.  Clinical, electrocardiographic and morphologic features of massive fatty deposits ("lipomatous hypertrophy") in the atrial septum.

Authors:  J Shirani; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

10.  Electrocardiographic observations in severe aortic valve stenosis: correlative necropsy study to clinical, hemodynamic,, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient.

Authors:  R J Siegel; W C Roberts
Journal:  Am Heart J       Date:  1982-02       Impact factor: 4.749

View more
  3 in total

1.  Predicting adverse cardiac events in sarcoidosis: deep learning from automated characterization of regional myocardial remodeling.

Authors:  Chenying Lu; Yi Grace Wang; Fahim Zaman; Xiaodong Wu; Mehul Adhaduk; Amanda Chang; Jiansong Ji; Tiemin Wei; Promporn Suksaranjit; Georgios Christodoulidis; Ernest Scalzetti; Yuchi Han; David Feiglin; Kan Liu
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-22       Impact factor: 2.357

2.  Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases.

Authors:  Osama Okasha; Felipe Kazmirczak; Ko-Hsuan Amy Chen; Afshin Farzaneh-Far; Chetan Shenoy
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

Review 3.  Diagnosis of cardiac sarcoidosis: a primer for non-imagers.

Authors:  Tanushree Agrawal; Yehia Saleh; Mohamad Hekmat Sukkari; Talal S Alnabelsi; Madiha Khan; Mahwash Kassi; Arvind Bhimaraj; Mouaz Al-Mallah
Journal:  Heart Fail Rev       Date:  2021-06-29       Impact factor: 4.654

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.